About: Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.93 (-8.04%)
XCUR NASDAQ Exicure Inc
Exicure Inc share price
Atividade de preço de XCUR
Último preço
$ 0,930
Variação (24h)
-0,08 USD (8,04%)
Volume
35.60K
Volume (média 4 sem.)
-
Abertura
$ 1,05
Variação do dia
$ 0,88 - $ 1,09
Fechamento anterior
$ 1,02
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
XCUR price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals